Treatment of disorder related to low cyclic GMP levels

Details Treatment of disorder related to low cyclic GMP levels Treatment of disorder related to low cyclic GMP levels

2002-12-19

2008-03-18

Marschel, Ardin H. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

07345079

ABSTRACT:
Disclosed in this invention is a method of treating a disorder associated with low cGMP levels. The method includes administering to a subject in need thereof an effective amount of a compound having a pyrazolyl core, a first aryl group bonded to 3-C of the pyrazolyl core, and a second aryl group fused at 4-C and 5-C of the pyrazolyl core. Also disclosed are pharmaceutical compositions containing these compounds.

REFERENCES:
patent: 5574168 (1996-11-01), Kuo et al.
patent: 6162819 (2000-12-01), Schindler et al.
patent: 6387942 (2002-05-01), Teng et al.
patent: 6518294 (2003-02-01), Teng et al.
patent: 1214339 (1999-04-01), None
patent: 0 908 456 (1999-04-01), None
patent: 02255970 (1990-10-01), None
Osol A. [Editor]. “Chapter 27: Structure-Activity Relationship and Drug Design”. Remington's Pharmaceutical Sciences (Sixteenth Edition). Mack Publishing, 1980. pp. 420-435.
Mayer et al., “cGMP Signalling Beyond Nitricoxide”, Trends in Pharmacological Sciences 22:546-548, 2001.
Tulis et al., “YC-1, a Benzyl Indazole derivative, Stimulates Vascular cGMP and Inhibits Neointima Formation”, Biochemical and Biophysical Research Communications 279:646-652, 2000.
Yu et al., “cGMP-Elevating Agents Suppress Proliferation of Vascular Smooth Muscle Cells by Inhibiting the Activation of Epidermal Growth Factor Signaling Pathway”, Circulation 95:1269-1277, 1997, XP002243240.
Yu et al., “Inhibition of Platelet Function by A02131-1, a Novel Inhibitor of cGMP-Specific Phosphodiesterase, In Vitro and In Vivo”, Blood 87:3758-3767, 1996, XP-002056082.

Affiliated with

Also associated with

Rating

Treatment of disorder related to low cyclic GMP levels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of disorder related to low cyclic GMP levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of disorder related to low cyclic GMP levels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3979821